FindTrial
Sign In

Comparing injection Remifentanil 0.1mcg/kg/min and 0.2mcg/kg/min To See the Changes In Heart rate, Blood Pressure And Pain relief In children of age group 5years to 12 years Undergoing testing for heart disease

A Prospective Observational Comparative Study Of Different Doses Of Remifentanil Infusion On Hemodynamics And Recovery In Children Undergoing Cardiac Catheterization - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/08/071968
Enrollment
30
Registered
2024-08-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Q252- Atresia of aorta Health Condition 2: Q255- Atresia of pulmonary artery Health Condition 3: Q211- Atrial septal defect Health Condition 4: Q212- Atrioventricular septal defect Health Condition 5: Q251- Coarctation of aorta Health Condition 6: Q239- Congenital malformation of aorticand mitral valves, unspecified Health Condition 7: Q209- Congenital malformation of cardiacchambers and connections, unspecified Health Condition 8: Q289- Congenital malformation of circulatory

Interventions

Intervention1: Remifentanil Hydrochloride: Dosage-0.1mcg/kg/minute Route of Administration - Intravenous Duration-Infusion Control Intervention1: Remifentanil Hydrochoride: Dosage-0.2mcg/kg/minute Rou

Sponsors

D Y Patil School Of Medicine
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age group between 5 years to 12 years 2. Children fit for cardiac catheterization.

Exclusion criteria

Exclusion criteria: 1.Parent’s refusal for consenting for cardiac catheterization.

Design outcomes

Primary

MeasureTime frame
To study the effect of different doses of remifentanil on hemodynamics in pediatric population undergoing cardiac catheterization. Timepoint: Sedation score every 5 minutes upto 60 minutes—

Secondary

MeasureTime frame
To study the complications of remifentanil in paediatric cardiac catheterizationTimepoint: Monitor complications every 5 minutes till end of procedure;•To study the recovery (Consciousness and orientation) in patients undergoing cardiac catheterization. Timepoint: Every 5 minutes for 60 minutes post procedure—

Countries

India

Contacts

Public ContactDr Manjula Sarkar

D Y Patil School Of Medicine

drmanjusarkar@gmail.com9869984017

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026